Cost of treatment: The single biggest obstacle to HIV/AIDS treatment adherence in lower-middle class patients in Mumbai, India

Indian Journal of Sexually Transmitted Diseases

Volumn 30, Issue 1, 2009, Pages 23-27

  Naik, Eknath ^a,d   Casanas, Beata ^a   Pazare, Amar ^b   Wabale, Gauri ^b   Sinnott, John ^a   Salihu, Hamisu ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b KEM HOSPITAL   (India)

^c USF   (Brazil)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adherence; Compliance; Cost; HIV AIDS; India; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALCOHOL ABUSE; ARTICLE; COST BENEFIT ANALYSIS; DRUG ABUSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SOCIAL CLASS;

EID: 77953467525     PISSN: 02537184     EISSN: 19983816     Source Type: Journal    
DOI: 10.4103/0253-7184.55476     Document Type: Article

References (17)

1. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
2. Williams AG. Adherence, Compliance, and HAART. AIDS Clinical Care 1997;9:51-55
3. UNGASS Country Progress Report 2008 India.National AIDS Control Organization, New Delhi, India. [retrieved on 2009 Jun 30]. Available from: http://data.unaids.org/pub/Report/2008/india-2008-country-progress-report-en. pdf.
4. NACO Surveillance Report 2006. [retrieved on 2009 Jun 30]. Available from: http://www.nacoonline.org/Quick-Links/HIV-Data/.
5. Lieb S, Brooks RG, Hopkins RS, Thompson D, Crockett LK, Liberti T, et al. Predicting death from HIV/AIDS: A case-control study from Florida public HIV/AIDS clinics. J Acquir Immune Defic Syndr 2002;30:351-358
6. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001;28:47-58.
7. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002;29:S2-10.
8. Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769
9. Gray L, Edmondson E, Lemke AL. University of Washington, School of Social Work; HIV/AIDS Project Development and Evaluation Unit. HIV treatment adherence: A guide for program development. 1998 October 31.
10. Webster RD, Barr D JD. Adherence to Highly Active Antiretroviral Therapy (HAART) among individuals with HIV/AIDS: A compendium of HAART adherence research, November 1997 - November 1999. Forum for Collaborative HIV Research. Center for Health Policy Research, George Washington University Medical Center, Washington, D.C.: 1999. p. 1-24.
11. Southik B. Indian drugs boss hails Aids deal. 2003, October 29. [retrieved on 2004 Feb 11]. Available from: BBC News Online http://news.bbc.co. uk/2/hi/south-asia/3220619.stm.
12. WHO. The 3 by 5 initiative. 2003. [retrieved 2004 Feb 11]. Available from: http://www.who.int/3by5/en/.
13. Deshmukh JS, Wadhva SK, Zodpey SP. AIDS: Knowledge and attitudes of university students in Nagpur. Indian J Med Sci 1998;52:302-308
14. Bentley ME, Spratt K, Shepherd ME, Gangakhedkar RR, Thilikavathi S, Bollinger RC, et al. HIV testing and counseling among men attending sexually transmitted disease clinics in Pune, India: Changes in condom use and sexual behavior over time. AIDS 1998;12:1869-1877
15. Joshi S, Joglekar N, Ghate M, Unni J, Risbud A, Bentley M, et al. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India. Indian J Med Res 2003;117:152-157
16. Sahasrabuddhe VV, Gholap TA, Jethava YS, Joglekar NS, Brahme RG, Gaikwad BA, et al. Patient-led partner referral in a district hospital based STD clinic. J Postgrad Med 2002;48:105-108
17. U.S. Public Health Service. Available from http://www.aidsinfo.nih. gov/ContentFiles/AdultandAdolescentGL.pdf. [Accessed on 2009 Apr 4].